Reviews - 3ovj mentioned but not cited (2)
- Alzheimer's disease--a panorama glimpse. Zhao LN, Lu L, Chew LY, Mu Y. Int J Mol Sci 15 12631-12650 (2014)
- General lack of structural characterization of chemically synthesized long peptides. Boutin JA, Tartar AL, van Dorsselaer A, Vaudry H. Protein Sci 28 857-867 (2019)
Articles - 3ovj mentioned but not cited (3)
Reviews citing this publication (25)
- Structural Studies of Amyloid Proteins at the Molecular Level. Eisenberg DS, Sawaya MR. Annu. Rev. Biochem. 86 69-95 (2017)
- Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease. Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Lozupone M, Santamato A, Zecca C, Barulli MR, Bellomo A, Pilotto A, Daniele A, Greco A, Logroscino G. Biomed Res Int 2016 3245935 (2016)
- Clinical development of curcumin in neurodegenerative disease. Hu S, Maiti P, Ma Q, Zuo X, Jones MR, Cole GM, Frautschy SA. Expert Rev Neurother 15 629-637 (2015)
- Amyloid-β positron emission tomography imaging probes: a critical review. Kepe V, Moghbel MC, Långström B, Zaidi H, Vinters HV, Huang SC, Satyamurthy N, Doudet D, Mishani E, Cohen RM, Høilund-Carlsen PF, Alavi A, Barrio JR. J. Alzheimers Dis. 36 613-631 (2013)
- Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery. Bu XL, Rao PPN, Wang YJ. Mol. Neurobiol. 53 3565-3575 (2016)
- Disrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal models. Attar A, Bitan G. Curr. Pharm. Des. 20 2469-2483 (2014)
- Structure and mechanism of action of tau aggregation inhibitors. Cisek K, Cooper GL, Huseby CJ, Kuret J. Curr Alzheimer Res 11 918-927 (2014)
- A flash in the pan: dissecting dynamic amyloid intermediates using fluorescence. Nath A, Rhoades E. FEBS Lett. 587 1096-1105 (2013)
- Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs). Shetty D, Kim YJ, Shim H, Snyder JP. Molecules 20 249-292 (2014)
- Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases. Giacomelli C, Daniele S, Martini C. Biochem. Pharmacol. 131 1-15 (2017)
- Natural product-based amyloid inhibitors. Velander P, Wu L, Henderson F, Zhang S, Bevan DR, Xu B. Biochem. Pharmacol. 139 40-55 (2017)
- Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents. Jouanne M, Rault S, Voisin-Chiret AS. Eur J Med Chem 139 153-167 (2017)
- NMR Meets Tau: Insights into Its Function and Pathology. Lippens G, Landrieu I, Smet C, Huvent I, Huvent I, Gandhi NS, Gigant B, Despres C, Qi H, Lopez J. Biomolecules 6 (2016)
- Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium. Seripa D, Solfrizzi V, Imbimbo BP, Daniele A, Santamato A, Lozupone M, Zuliani G, Greco A, Logroscino G, Panza F. Expert Rev Neurother 16 259-277 (2016)
- Pharmacological Modulators of Tau Aggregation and Spreading. Dominguez-Meijide A, Vasili E, Outeiro TF. Brain Sci 10 E858 (2020)
- What amyloid ligands can tell us about molecular polymorphism and disease. LeVine H, Walker LC. Neurobiol. Aging 42 205-212 (2016)
- Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules. Rauch JN, Olson SH, Gestwicki JE. Cold Spring Harb Perspect Med 7 (2017)
- The Interplay of the Unfolded Protein Response in Neurodegenerative Diseases: A Therapeutic Role of Curcumin. Mukherjee S, Mishra AK, Peer GDG, Bagabir SA, Haque S, Pandey RP, Raj VS, Jain N, Pandey A, Kar SK. Front Aging Neurosci 13 767493 (2021)
- The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention? Fichou Y, Al-Hilaly YK, Devred F, Smet-Nocca C, Tsvetkov PO, Verelst J, Winderickx J, Geukens N, Vanmechelen E, Perrotin A, Serpell L, Hanseeuw BJ, Medina M, Buée L, Landrieu I. Acta Neuropathol Commun 7 31 (2019)
- Untangling the Tauopathy for Alzheimer's disease and parkinsonism. Chang HY, Sang TK, Chiang AS. J. Biomed. Sci. 25 54 (2018)
- The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET. Mohammadi Z, Alizadeh H, Marton J, Cumming P. Biomolecules 13 290 (2023)
- A review of curcumin as a biological stain and as a self-visualizing pharmaceutical agent. Hope-Roberts M, Horobin RW. Biotech Histochem 92 315-323 (2017)
- Elucidating Tau function and dysfunction in the era of cryo-EM. Lippens G, Gigant B. J. Biol. Chem. 294 9316-9325 (2019)
- Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status. Pinzi L, Bisi N, Sorbi C, Franchini S, Tonali N, Rastelli G. Molecules 28 4544 (2023)
- Translational opportunities for amyloid-targeting fluorophores. Cao KJ, Yang J. Chem. Commun. (Camb.) 54 9107-9118 (2018)